Novel druggable mechanism of Parkinson's disease: Potential therapeutics and underlying pathogenesis based on ferroptosis

Endogenous formaldehyde scavenges cellular glutathione resulting in redox disruption and cytotoxicity

(2022) Carla Umansky et al.   Nature Communications

DJ-1 upregulates the Nrf2/GPX4 signal pathway to inhibit trophoblast ferroptosis in the pathogenesis of preeclampsia

(2022) Tingting Liao et al.   Scientific Reports

Emerging Mechanisms and Disease Implications of Ferroptosis: Potential Applications of Natural Products

(2022) Chun Ge et al.   Frontiers in Cell and Developmental Biology

Identification of Novel Oxindole Compounds That Suppress ER Stress-Induced Cell Death as Chemical Chaperones

(2022) Yuto Hasegawa et al.   ACS Chemical Neuroscience

Discovery of novel diphenylbutene derivative ferroptosis inhibitors as neuroprotective agents

(2022) Yuying Fang et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

2,2,6,6-Tetramethylpiperidine-1-oxyl acts as a volatile inhibitor of ferroptosis and neurological injury

(2022) Hiroyuki Mizuno et al.   JOURNAL OF BIOCHEMISTRY

Ferroptosis in Parkinson’s disease: glia–neuron crosstalk

(2022) Zhang-Li Wang et al.   TRENDS IN MOLECULAR MEDICINE

Mitochondria bridge HIF signaling and ferroptosis blockage in acute kidney injury

(2022) Wenju Li et al.   Cell Death & Disease

Targeting ferroptosis protects against experimental (multi)organ dysfunction and death

(2022) Samya Van Coillie et al.   Nature Communications

Endothelial cell ferroptosis mediates monocrotaline-induced pulmonary hypertension in rats by modulating NLRP3 inflammasome activation

(2022) Shan-Shan Xie et al.   Scientific Reports

Geniposide Possesses the Protective Effect on Myocardial Injury by Inhibiting Oxidative Stress and Ferroptosis via Activation of the Grsf1/GPx4 Axis

(2022) Yuehong Shen et al.   Frontiers in Pharmacology

LPCAT3 Inhibitors Remodel the Polyunsaturated Phospholipid Content of Human Cells and Protect from Ferroptosis

(2022) Alex Reed et al.   ACS Chemical Biology

Dexmedetomidine Attenuates Ferroptosis-Mediated Renal Ischemia/Reperfusion Injury and Inflammation by Inhibiting ACSL4 via α2-AR

(2022) Wen-hui Tao et al.   Frontiers in Pharmacology

Therapeutic Insights on Ferroptosis in Parkinson's disease

(2022) Komal Thapa et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Bis-isatin derivatives: design, synthesis, and biological activity evaluation as potent dimeric DJ-1 inhibitors

(2021) Xiao-bing Chen et al.   ACTA PHARMACOLOGICA SINICA

Ferroptosis: mechanisms, biology and role in disease

(2021) Xuejun Jiang et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Role of Ferroptosis in Neurological Diseases

(2021) Min-Yi Yao et al.   NEUROSCIENCE LETTERS

Selective Ferroptosis Inhibitor Liproxstatin-1 Attenuates Neurological Deficits and Neuroinflammation After Subarachnoid Hemorrhage

(2021) Yang Cao et al.   Neuroscience Bulletin

Mechanisms of Intranasal Deferoxamine in Neurodegenerative and Neurovascular Disease

(2021) Jacob Kosyakovsky et al.   Pharmaceuticals

A novel treatment strategy to prevent Parkinson’s disease: focus on iron regulatory protein 1 (IRP1)

(2021) Thomas M. Berry et al.   INTERNATIONAL JOURNAL OF NEUROSCIENCE

Thioredoxin-1 Rescues MPP+/MPTP-Induced Ferroptosis by Increasing Glutathione Peroxidase 4

(2021) Liping Bai et al.   MOLECULAR NEUROBIOLOGY

Phospholipase iPLA2β averts ferroptosis by eliminating a redox lipid death signal

(2021) Wan-Yang Sun et al.   Nature Chemical Biology

Benefits of Iron Chelators in the Treatment of Parkinson’s Disease

(2021) Xiaoyan Zeng et al.   NEUROCHEMICAL RESEARCH

Ferroptosis and its potential as a therapeutic target

(2021) Hanshu Yuan et al.   BIOCHEMICAL PHARMACOLOGY

Regulating inflammation associated Ferroptosis-a treatment strategy for Parkinson disease

(2021) Marthandam Asokan Shibu et al.   CURRENT MEDICINAL CHEMISTRY

Apoferritin: a potential nanocarrier for cancer imaging and drug delivery

(2021) Hanitrarimalala Veroniaina et al.   Expert Review of Anticancer Therapy

Nrf2 as a potential target for Parkinson’s disease therapy

(2021) Yingcai Niu et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Parkinson's disease

(2021) Bastiaan R Bloem et al.   LANCET

Baicalin induces ferroptosis in bladder cancer cells by downregulating FTH1

(2021) Na Kong et al.   Acta Pharmaceutica Sinica B

Apoferritin improves motor deficits in MPTP-treated mice by regulating brain iron metabolism and ferroptosis

(2021) Li-Mei Song et al.   iScience

Super-enhancer-driven Sorting Nexin 5 expression promotes dopaminergic neuronal ferroptosis in Parkinson's disease models

(2021) Wenwen Si et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Molecular mechanisms of cell death in neurological diseases

(2021) Diane Moujalled et al.   CELL DEATH AND DIFFERENTIATION

NLRP3 inflammasome activation and cell death

(2021) Yi Huang et al.   Cellular & Molecular Immunology

Discovery of phloroglucinols from Hypericum japonicum as ferroptosis inhibitors

(2021) Xing Peng et al.   FITOTERAPIA

Ferroptosis: A potential therapeutic target for neurodegenerative diseases

(2021) D. Vitalakumar et al.   JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY

Resveratrol attenuates rotenone-induced inflammation and oxidative stress via STAT1 and Nrf2/Keap1/SLC7A11 pathway in a microglia cell line

(2021) Wei Sun et al.   PATHOLOGY RESEARCH AND PRACTICE

Regulation of ferroptosis by bioactive phytochemicals: Implications for medical nutritional therapy

(2021) Kai Zheng et al.   PHARMACOLOGICAL RESEARCH

Iron regulatory protein 1 promotes ferroptosis by sustaining cellular iron homeostasis in melanoma

(2021) Fengping Yao et al.   Oncology Letters

iPLA2β-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4

(2021) Delin Chen et al.   Nature Communications

Mechanisms of Modulation of Ferroptosis and Its Role in Central Nervous System Diseases

(2021) Qingyun Tan et al.   Frontiers in Pharmacology

The Ferroptosis-NLRP1 Inflammasome: The Vicious Cycle of an Adverse Pregnancy

(2021) Li Meihe et al.   Frontiers in Cell and Developmental Biology

A Dual PI3K/HDAC Inhibitor Induces Immunogenic Ferroptosis to Potentiate Cancer Immune Checkpoint Therapy

(2021) Fushun Fan et al.   CANCER RESEARCH

Radical-Trapping Antioxidant Activity of Copper and Nickel Bis(Thiosemicarbazone) Complexes Underlies Their Potency as Inhibitors of Ferroptotic Cell Death

(2021) Omkar Zilka et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Ferroptosis: copper-iron connection in cuprizone-induced demyelination

(2021) Samuel David et al.   Neural Regeneration Research

Ferroptosis Mediated by Lipid Reactive Oxygen Species: A Possible Causal Link of Neuroinflammation to Neurological Disorders

(2021) Ying Cheng et al.   Oxidative Medicine and Cellular Longevity

Britanin relieves ferroptosis-mediated myocardial ischaemia/reperfusion damage by upregulating GPX4 through activation of AMPK/GSK3β/Nrf2 signalling

(2021) Haoyang Lu et al.   PHARMACEUTICAL BIOLOGY

Licofelone, a potent COX/5-LOX inhibitor and a novel option for treatment of neurological disorders

(2021) Seyed Mehrad Razavi et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Insight into the Double-Edged Role of Ferroptosis in Disease

(2021) Lei Zhang et al.   Biomolecules

The Regulatory Effects and the Signaling Pathways of Natural Bioactive Compounds on Ferroptosis

(2021) Shenshen Zhang et al.   Foods

Phospholipase iPLA2β acts as a guardian against ferroptosis

(2021) Chao Mao et al.   Cancer Communications

Ferroptosis as a Major Factor and Therapeutic Target for Neuroinflammation in Parkinson’s Disease

(2021) Chih-Jan Ko et al.   Biomedicines

Cobalt nanoparticles trigger ferroptosis‐like cell death (oxytosis) in neuronal cells: Potential implications for neurodegenerative disease

(2020) Govind Gupta et al.   FASEB JOURNAL

Conservative iron chelation for neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis

(2020) David Devos et al.   JOURNAL OF NEURAL TRANSMISSION

DJ-1 suppresses ferroptosis through preserving the activity of S-adenosyl homocysteine hydrolase

(2020) Ji Cao et al.   Nature Communications

Clioquinol improves motor and non-motor deficits in MPTP-induced monkey model of Parkinson’s disease through AKT/mTOR pathway

(2020) Liangqin Shi et al.   Aging-US

SnapShot: Ferroptosis

(2020) Kamyar Hadian et al.   CELL

Ferroptosis was more initial in cell death caused by iron overload and its underlying mechanism in Parkinson's disease

(2020) Pei Zhang et al.   FREE RADICAL BIOLOGY AND MEDICINE

Cysteine depletion induces pancreatic tumor ferroptosis in mice

(2020) Michael A. Badgley et al.   SCIENCE

Design and evaluation of bi-functional iron chelators for protection of dopaminergic neurons from toxicants

(2020) Simon Gutbier et al.   ARCHIVES OF TOXICOLOGY

The emerging role of ferroptosis in inflammation

(2020) Yitian Sun et al.   BIOMEDICINE & PHARMACOTHERAPY

Rational design, synthesis and biological evaluation of novel multitargeting anti-AD iron chelators with potent MAO-B inhibitory and antioxidant activity

(2020) Xiaoying Jiang et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Inflammasomes

(2020) Natália Ketelut-Carneiro et al.   CURRENT BIOLOGY

Ferroptosis and its potential role in the physiopathology of Parkinson’s Disease

(2020) Laura Mahoney-Sánchez et al.   PROGRESS IN NEUROBIOLOGY

Vacancies on 2D transition metal dichalcogenides elicit ferroptotic cell death

(2020) Shujuan Xu et al.   Nature Communications

Intrastriatal administration of coenzyme Q10 enhances neuroprotection in a Parkinson’s disease rat model

(2020) Hyung Woo Park et al.   Scientific Reports

N-Acetylcysteine Nanocarriers Protect against Oxidative Stress in a Cellular Model of Parkinson’s Disease

(2020) Leah Mursaleen et al.   Antioxidants

Genetics of Parkinson's disease

(2020) Ajith Cherian et al.   ACTA NEUROLOGICA BELGICA

The C terminus of DJ-1 determines its homodimerization, MGO detoxification activity and suppression of ferroptosis

(2020) Li Jiang et al.   ACTA PHARMACOLOGICA SINICA

New inhibitor targeting Acyl-CoA synthetase 4 reduces breast and prostate tumor growth, therapeutic resistance and steroidogenesis

(2020) Ana F. Castillo et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Hydroxypyridinone-Based Iron Chelators with Broad-Ranging Biological Activities

(2020) Xiaoying Jiang et al.   JOURNAL OF MEDICINAL CHEMISTRY

FTH1 Inhibits Ferroptosis Through Ferritinophagy in the 6-OHDA Model of Parkinson’s Disease

(2020) Ye Tian et al.   Neurotherapeutics

The Application of Ferroptosis in Diseases

(2020) Yangmin Qiu et al.   PHARMACOLOGICAL RESEARCH

Ginkgetin derived from Ginkgo biloba leaves enhances the therapeutic effect of cisplatin via ferroptosis-mediated disruption of the Nrf2/HO-1 axis in EGFR wild-type non-small-cell lung cancer

(2020) Jian-Shu Lou et al.   PHYTOMEDICINE

Antiferroptotic Activity of Phenothiazine Analogues: A Novel Therapeutic Strategy for Oxidative Stress Related Disease

(2020) Jun Liu et al.   ACS Medicinal Chemistry Letters

Therapeutic role of inflammasome inhibitors in neurodegenerative disorders

(2020) Behnaz Lahooti et al.   BRAIN BEHAVIOR AND IMMUNITY

α‐Lipoic acid alleviates ferroptosis in the MPP + ‐induced PC12 cells via activating the PI3K/Akt/Nrf2 pathway

(2020) Lin Liu et al.   CELL BIOLOGY INTERNATIONAL

Quality of life in Parkinson's disease: A systematic review and meta‐analysis of comparative studies

(2020) Na Zhao et al.   CNS Neuroscience & Therapeutics

Epigenetic regulators of neuronal ferroptosis identify novel therapeutics for neurological diseases: HDACs, transglutaminases, and HIF prolyl hydroxylases

(2020) Orjon Rroji et al.   NEUROBIOLOGY OF DISEASE

Idebenone Ameliorates Rotenone-Induced Parkinson’s Disease in Rats Through Decreasing Lipid Peroxidation

(2020) Bahattin Avcı et al.   NEUROCHEMICAL RESEARCH

Posttranslational Modifications in Ferroptosis

(2020) Xiang Wei et al.   Oxidative Medicine and Cellular Longevity

Formaldehyde induces ferroptosis in hippocampal neuronal cells by upregulation of the Warburg effect

(2020) Xiao-Na Li et al.   TOXICOLOGY

Chemically Induced Models of Parkinson’s Disease: History and Perspectives for the Involvement of Ferroptosis

(2020) Shuheng Wen et al.   Frontiers in Cellular Neuroscience

NCOA4-Mediated Ferritinophagy: A Potential Link to Neurodegeneration

(2019) Maria Quiles del Rey et al.   Frontiers in Neuroscience

Noxious Iron–Calcium Connections in Neurodegeneration

(2019) Marco Tulio Núñez et al.   Frontiers in Neuroscience

The release and activity of HMGB1 in ferroptosis

(2019) Qirong Wen et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Hemin-induced platelet activation and ferroptosis is mediated through ROS-driven proteasomal activity and inflammasome activation: Protection by Melatonin

(2019) Somanathapura K. NaveenKumar et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Selenium Drives a Transcriptional Adaptive Program to Block Ferroptosis and Treat Stroke

(2019) Ishraq Alim et al.   CELL

Impaired iPLA2β activity affects iron uptake and storage without iron accumulation: An in vitro study excluding decreased iPLA2β activity as the cause of iron deposition in PLAN

(2019) Yu-pei Guo et al.   BRAIN RESEARCH

N‐Acetyl Cysteine Is Associated With Dopaminergic Improvement in Parkinson's Disease

(2019) Daniel A. Monti et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Interactions between iron and α-synuclein pathology in Parkinson's disease

(2019) Bingbing Chen et al.   FREE RADICAL BIOLOGY AND MEDICINE

The genetic architecture of Parkinson's disease

(2019) Cornelis Blauwendraat et al.   LANCET NEUROLOGY

Cu II (atsm) inhibits ferroptosis: implications for treatment of neurodegenerative disease

(2019) Authors Adam Southon et al.   BRITISH JOURNAL OF PHARMACOLOGY

Parkinson disease

(2019) R. Balestrino et al.   EUROPEAN JOURNAL OF NEUROLOGY

Why should neuroscientists worry about iron? The emerging role of ferroptosis in the pathophysiology of neuroprogressive diseases

(2018) Gerwyn Morris et al.   BEHAVIOURAL BRAIN RESEARCH

Selenium Utilization by GPX4 Is Required to Prevent Hydroperoxide-Induced Ferroptosis

(2018) Irina Ingold et al.   CELL

The role of Ca 2+ in cell death caused by oxidative glutamate toxicity and ferroptosis

(2018) Pamela Maher et al.   CELL CALCIUM

Coenzyme Q10: From bench to clinic in aging diseases, a translational review

(2018) Francisco M. Gutierrez-Mariscal et al.   CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION

Deuterium-reinforced linoleic acid lowers lipid peroxidation and mitigates cognitive impairment in the Q140 knock in mouse model of Huntington's disease

(2018) Asa Hatami et al.   FEBS Journal

Novel Allosteric Activators for Ferroptosis Regulator Glutathione Peroxidase 4

(2018) Cong Li et al.   JOURNAL OF MEDICINAL CHEMISTRY

Iron as a therapeutic target for Parkinson's disease

(2018) Caroline Moreau et al.   MOVEMENT DISORDERS

Novel oxindole derivatives prevent oxidative stress-induced cell death in mouse hippocampal HT22 cells

(2018) Yoko Hirata et al.   NEUROPHARMACOLOGY

The genetic landscape of Parkinson's disease

(2018) A. Lunati et al.   REVUE NEUROLOGIQUE

Discovery of Novel, Drug-Like Ferroptosis Inhibitors with in Vivo Efficacy

(2018) Lars Devisscher et al.   JOURNAL OF MEDICINAL CHEMISTRY

RSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal Cancer

(2018) Xinbing Sui et al.   Frontiers in Pharmacology

Activation of Glutathione Peroxidase 4 as a Novel Anti-inflammatory Strategy

(2018) Cong Li et al.   Frontiers in Pharmacology

Repeated-Dose Oral N-Acetylcysteine in Parkinson's Disease: Pharmacokinetics and Effect on Brain Glutathione and Oxidative Stress

(2017) Lisa D. Coles et al.   JOURNAL OF CLINICAL PHARMACOLOGY

The NLRP3 Inflammasome is Involved in the Pathogenesis of Parkinson’s Disease in Rats

(2017) Zhijuan Mao et al.   NEUROCHEMICAL RESEARCH

Ferroptosis and cell death mechanisms in Parkinson's disease

(2017) Stephanie J. Guiney et al.   NEUROCHEMISTRY INTERNATIONAL

The effects of omega-3 fatty acids and vitamin E co-supplementation on clinical and metabolic status in patients with Parkinson's disease: A randomized, double-blind, placebo-controlled trial

(2017) Mohsen Taghizadeh et al.   NEUROCHEMISTRY INTERNATIONAL

Ferroptosis Inhibition: Mechanisms and Opportunities

(2017) Jose Pedro Friedmann Angeli et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Phase IIb Study of Intranasal Glutathione in Parkinson’s Disease

(2017) Laurie K. Mischley et al.   Journal of Parkinsons Disease

Parkinson disease

(2017)   Nature Reviews Disease Primers

Parkinson disease

(2017) Werner Poewe et al.   Nature Reviews Disease Primers

Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson’s disease

(2017) Antonio Martin-Bastida et al.   Scientific Reports

Epigenetic regulation in Parkinson’s disease

(2016) Catherine Labbé et al.   ACTA NEUROPATHOLOGICA

Identification of baicalein as a ferroptosis inhibitor by natural product library screening

(2016) Yangchun Xie et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Novel Ferroptosis Inhibitors with Improved Potency and ADME Properties

(2016) Sam Hofmans et al.   JOURNAL OF MEDICINAL CHEMISTRY

Cdk5-Dependent Activation of Neuronal Inflammasomes in Parkinson's Disease

(2016) Pei Zhang et al.   MOVEMENT DISORDERS

Science-led economies

(2016) Herb Brody   NATURE

ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition

(2016) Sebastian Doll et al.   Nature Chemical Biology

Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis

(2016) Kenichi Shimada et al.   Nature Chemical Biology

Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC

(2016) Bruce Do Van et al.   NEUROBIOLOGY OF DISEASE

A Mitochondrial-Targeted Nitroxide Is a Potent Inhibitor of Ferroptosis

(2016) Tanja Krainz et al.   ACS Central Science

N-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line Data

(2016) Daniel A. Monti et al.   PLoS One

A randomized, double-blind phase I/IIa study of intranasal glutathione in Parkinson's disease

(2015) Laurie K. Mischley et al.   MOVEMENT DISORDERS

Selenium reduces bradykinesia and DNA damage in a rat model of Parkinson's disease

(2015) Joel Henrique Ellwanger et al.   NUTRITION

Cerebrospinal fluid concentrations of N-acetylcysteine after oral administration in Parkinson's disease

(2015) Maya Katz et al.   PARKINSONISM & RELATED DISORDERS

Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's disease

(2015) Asako Yoritaka et al.   PARKINSONISM & RELATED DISORDERS

Does High-Dose Coenzyme Q10 Improve Oxidative Damage and Clinical Outcomes in Parkinson's Disease?

(2014) Raymond Chee-Seong Seet et al.   ANTIOXIDANTS & REDOX SIGNALING

Ferrostatins Inhibit Oxidative Lipid Damage and Cell Death in Diverse Disease Models

(2014) Rachid Skouta et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice

(2014) Jose Pedro Friedmann Angeli et al.   NATURE CELL BIOLOGY

Combined Therapy of Iron Chelator and Antioxidant Completely Restores Brain Dysfunction Induced by Iron Toxicity

(2014) Jirapas Sripetchwandee et al.   PLoS One

Synchronized renal tubular cell death involves ferroptosis

(2014) Andreas Linkermann et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease

(2014) et al.   JAMA Neurology

Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease

(2013) David Devos et al.   ANTIOXIDANTS & REDOX SIGNALING

Propylisopropylacetic acid (PIA), a constitutional isomer of valproic acid, uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: A potential drug for bipolar disorder

(2013) Hiren R. Modi et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

N-acetylcysteine Boosts Brain and Blood Glutathione in Gaucher and Parkinson Diseases

(2013) Mary J. Holmay et al.   CLINICAL NEUROPHARMACOLOGY

Hypoxia-inducible factor prolyl hydroxylases as targets for neuroprotection by “antioxidant” metal chelators: From ferroptosis to stroke

(2013) Rachel E. Speer et al.   FREE RADICAL BIOLOGY AND MEDICINE

Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death

(2012) Scott J. Dixon et al.   CELL

The hypoxia imaging agent Cu II (atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson’s disease

(2012) Lin W. Hung et al.   JOURNAL OF EXPERIMENTAL MEDICINE

A pilot trial of deferiprone for neurodegeneration with brain iron accumulation

(2011) G. Abbruzzese et al.   HAEMATOLOGICA

Binding and uptake of H-ferritin are mediated by human transferrin receptor-1

(2010) Li Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's disease

(2009) Robert A. Hauser et al.   MOVEMENT DISORDERS

Excessive S-adenosyl-l-methionine-dependent methylation increases levels of methanol, formaldehyde and formic acid in rat brain striatal homogenates: Possible role in S-adenosyl-l-methionine-induced Parkinson's disease-like disorders

(2008) Eun-Sook Lee et al.   LIFE SCIENCES